Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Jun 2014. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 80071701000001117 | Anoro Ellipta | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 80071801000001114 | Anoro Ellipta (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Anoro Ellipta | Is a | Trade family | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler (Pharmaram Ltd) | Is a | True | Anoro Ellipta | Inferred relationship | Existential restriction modifier | |
| Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) | Is a | True | Anoro Ellipta | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR